Research
Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.
Latest stories
Research
December 22, 2025
Gastroenterology
December 17, 2025
Research
December 16, 2025
Research
December 15, 2025
Research
December 15, 2025
Research
December 15, 2025
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community